We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+1.97%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$32.2B
AUM Growth
+$1.15B
Cap. Flow
+$886M
Cap. Flow %
2.75%
Top 10 Hldgs %
14.34%
Holding
3,060
New
26
Increased
2,469
Reduced
354
Closed
63

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$23.3M
2
XOM icon
ExxonMobil
XOM
+$22.8M
3
AAPL icon
Apple
AAPL
+$21.5M
4
WFC icon
Wells Fargo
WFC
+$19.8M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$17.3M

Sector Composition

Rank Sector Weight
1 Technology 14.4%
2 Financials 14.39%
3 Healthcare 13.67%
4 Industrials 10.84%
5 Consumer Discretionary 9.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ESNT icon
1726
Essent Group
ESNT
$6.14B
$1.11M ﹤0.01%
53,322
+30
+0.1% +$574
SASR
1727
DELISTED
Sandy Spring Bancorp Inc
SASR
$1.11M ﹤0.01%
39,767
+2,980
+8% +$78.8K
LQ
1728
DELISTED
La Quinta Holdings Inc.
LQ
$1.11M ﹤0.01%
88,562
+790
+0.9% +$8.97K
RP
1729
DELISTED
RealPage, Inc.
RP
$1.1M ﹤0.01%
53,019
+500
+1% +$9.91K
RGS icon
1730
Regis Corp
RGS
$66.2M
$1.1M ﹤0.01%
3,629
+146
+4% +$42.3K
ZEN
1731
DELISTED
ZENDESK INC
ZEN
$1.1M ﹤0.01%
52,698
+285
+0.5% +$5.79K
PLAB icon
1732
Photronics
PLAB
$1.92B
$1.1M ﹤0.01%
105,714
+9,520
+10% +$103K
KKD
1733
DELISTED
KRISPY KREME DOUGHNUTS INC
KKD
$1.1M ﹤0.01%
70,573
+285
+0.4% +$4.14K
UTEK
1734
DELISTED
Ultratech Inc.
UTEK
$1.09M ﹤0.01%
49,962
+4,495
+10% +$88.7K
GSK icon
1735
GSK
GSK
$103B
$1.09M ﹤0.01%
21,480
+240
+1% +$12K
STBZ
1736
DELISTED
State Bank Financial Corporation. Common Stock
STBZ
$1.08M ﹤0.01%
54,841
+6,225
+13% +$121K
NBHC icon
1737
National Bank Holdings
NBHC
$1.94B
$1.08M ﹤0.01%
53,023
+1,175
+2% +$23.2K
RUSHA icon
1738
Rush Enterprises Class A
RUSHA
$6.43B
$1.07M ﹤0.01%
132,482
+11,621
+10% +$93.7K
TRST
1739
Trustco Bank Corp NY
TRST
$983M
$1.07M ﹤0.01%
35,439
+3,573
+11% +$102K
NWLI
1740
DELISTED
National Western Life Group, Inc. Class A
NWLI
$1.07M ﹤0.01%
4,653
+430
+10% +$95K
PRIM icon
1741
Primoris Services
PRIM
$4.93B
$1.07M ﹤0.01%
44,026
+2,315
+6% +$49.4K
CKEC
1742
DELISTED
Carmike Cinemas Inc
CKEC
$1.07M ﹤0.01%
35,564
+3,275
+10% +$79.4K
ICFI icon
1743
ICF International
ICFI
$1.56B
$1.07M ﹤0.01%
31,013
+3,195
+11% +$107K
PINC
1744
DELISTED
Premier
PINC
$1.07M ﹤0.01%
31,956
-850
-3% -$27.7K
RSE
1745
DELISTED
ROUSE PPTYS INC COM (DE)
RSE
$1.07M ﹤0.01%
57,988
+5,955
+11% +$103K
IRDM icon
1746
Iridium Communications
IRDM
$5.26B
$1.06M ﹤0.01%
135,341
+13,420
+11% +$96.4K
NHC icon
1747
National Healthcare
NHC
$3.25B
$1.06M ﹤0.01%
17,100
+1,870
+12% +$116K
SNY icon
1748
Sanofi
SNY
$102B
$1.06M ﹤0.01%
26,510
MSGN
1749
DELISTED
MSG Networks Inc.
MSGN
$1.06M ﹤0.01%
61,558
-1,320
-2% -$23K
PTLA
1750
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$1.06M ﹤0.01%
51,950
+2,580
+5% +$81.9K

Similar funds

RhumbLine Advisers's Q1 2016 Portfolio in Review

As of Q1 2016, RhumbLine Advisers held 3,060 positions worth $32.2B, up 3.7% from $31.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Trading was light in Q1 2016: portfolio turnover was 2.9%. RhumbLine Advisers opened 26 new positions and exited 63, leaving the 3,060-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q1 2016 buy was Willis Towers Watson: 89,353 shares worth $10.6M.
  • RhumbLine Advisers added most to Broadcom in Q1 2016, an estimated $23.3M increase.
  • RhumbLine Advisers's biggest Q1 2016 reduction was Chubb, cutting an estimated $13.7M.
  • RhumbLine Advisers fully exited BROADCOM CORP CL-A in Q1 2016, selling an estimated $43M.
  • RhumbLine Advisers's ten largest holdings make up 14% of its $32.2B portfolio in Q1 2016.
  • RhumbLine Advisers opened 26 new positions and closed 63 in Q1 2016.
  • RhumbLine Advisers's portfolio value rose 3.7% quarter-over-quarter to $32.2B.

Based on RhumbLine Advisers's 13F filing for Q1 2016, filed 2 May 2016.